期刊
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
卷 13, 期 1, 页码 27-36出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2014.04.039
关键词
Liver Disease; Cirrhosis; Fibrosis; Hepatitis; Nonalcoholic Fatty Liver Disease
With widespread screening and increasingly effective treatments for patients with viral hepatitis as well as the increasing prevalence of nonalcoholic fatty liver disease, the population presenting to the care of gastroenterologists and hepatologists is certain to increase. Assessment of advanced liver disease is traditionally invasive and expensive. Vibration-controlled transient elastography, commonly delivered by the FibroScan device, is an option recently approved by the Food and Drug Administration for the noninvasive assessment of liver disease at the point of care. Herein, we review the promise and pitfalls of vibration-controlled transient elastography with the aim of providing clinicians with a framework to interpret its results and apply this technology to the changing needs of our patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据